Bloomberg @business
Troubled biotech Bluebird foresees a delay in its application for FDA approval of its sickle cell drug candidate https://t.co/9kcopxQfSL — PolitiTweet.org
Created
Wed Mar 29 13:00:27 +0000 2023
Likes
5
Retweets
2
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Bloomberg @business
Troubled biotech Bluebird foresees a delay in its application for FDA approval of its sickle cell drug candidate https://t.co/9kcopxQfSL — PolitiTweet.org